Mayo Clinic Rochester

Jan 14, 2025 | academic.oup.com | Mayo Clinic Arizona |Mayo Clinic Rochester

Cystic breast masses are a common entity encountered by breast radiologists. The imaging features of benign and malignant cystic masses may overlap, causing confusion and miscategorization with the potential to produce diagnostic delay and harm. This article provides a review of key differentiating imaging features that help guide appropriate mass characterization and treatment. © Society of Breast Imaging 2025. All rights reserved.

Jan 13, 2025 | translational-medicine.biomedcentral.com | Mayo Clinic Rochester

The human MM cell lines NCI-H929, L-363, and KMS-12-PE were generously provided by Professor Seiji Okada from the Center for AIDS Research and Graduate School of Medical Sciences, Division of Hematopoiesis, Kumamoto University, Japan. SupT-1 cell lines, derived from human T cell lymphoblastic lymphoma, were procured from the American Type Culture Collection (ATCC) (Cat# CRL-1942, RRID: CVCL_1714, Manassas, VA, USA).

Dec 4, 2024 | academic.oup.com | Mayo Clinic Rochester |Mayo Clinic Arizona

We aim to explore the role of mechanistic target of rapamycin complex (mTORC) 2 in systemic lupus erythematosus (SLE) development, the in vivo regulation of mTORC2 by type I interferon (IFN) signaling in autoimmunity, and to use mTORC2 targeting therapy to ameliorate lupus-like symptoms in an in vivo lupus mouse model and an in vitro coculture model using human PBMCs. We first induced lupus-like disease in T cell specific Rictor, a key component of mTORC2, deficient mice by topical...

Dec 3, 2024 | aacrjournals.org | San Juan |Puerto Rico |Mayo Clinic Rochester

Gastric adenocarcinoma (GAC) is the fourth leading global cause of cancer mortality and leading infection-associated cancer. High-incidence regions of GAC include Latin America and Eastern Asia. Immigrants from high-incidence regions maintain their GAC risk. GAC is a major U.S. cancer disparity, and its incidence rates are 2 to 10 times higher in non-White populations. Emerging guidelines recommend 3-year surveillance endoscopy for patients with high-risk gastric premalignant conditions (GPMC).

Jun 29, 2024 | telehealthandmedicinetoday.com | Sarah Harper |B.Sc. MD |Biomedical Informatics |Mayo Clinic Rochester

Failing is an important issue for businesses. Embracing it moves markets, insures consumer safety, and spares unnecessary investment. Are the aviation and nuclear power industries the only industries to truly embrace it and share learnings to fortify standards and best practices? Can healthcare do the same? Telehealth and Medicine Today (THMT) is pleased to spotlight the critical necessity to face failure personally and professionally. Do we place too much emphasis on failure avoidance vs.